Mirror Biologics and Immunovative Therapies announce publication of the technical rationale for development of a universal anti-viral vaccine targeted to protect eldery adults from COVID-19 and any future novel virus outbreaks.

Mirror Biologics, Inc. (“MBI”), the commercial development arm of Israel-based Immunovative Therapies, Ltd. (“ITL”) together with the Hadassah-Hebrew University Medical Center’s Center for Immunotherapy and Immunobiology Research today announce the publication of a...

AI-based precision medicine mining of UK Biobank finds 13 human COVID risk genes and identifies 59 drugs with potential to improve survival in severe COVID-19 patients and sepsis

70 sepsis risk genes identified from UK Biobank, 61% of which are present specifically in severe COVID-19 patients (‘COVID risk genes’) 13 ‘COVID risk genes’ identified as known druggable targets 59 compounds and drugs identified with potential for accelerated drug...